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Cardiac myocytes are presumed to enlarge with left ventricular hypertrophy (LVH). This study correlates histologically measured
myocytes with lean and fat body mass. Cases of LVH without coronary heart disease and normal controls came from forensic
autopsies. The cross-sectional widths of myocytes in H&E-stained paraﬃn sections followed log normal distributions almost to
perfection in all 104 specimens, with constant coeﬃcient of variation across the full range of ventricular weight, as expected
if myocytes of all sizes contribute proportionately to hypertrophy. Myocyte sizes increased with height. By regression analysis,
height2.7 as a proxy for lean body mass and body mass index (BMI) as a proxy for fat body mass, exerted equal eﬀects in the
multiple correlation with myocyte volume, and the equation rejected race and sex. In summary, myocyte sizes, as indexes of LVH,
suggest that lean and fat body mass may contribute equally.
1.Introduction
Early reports concerning myocyte size in the human left
ventricle, relying heavily upon autopsy specimens [1–3],
often found that [4] “the individual contractile muscle cells
... are roughly cylindrical ... measuring 17 to 25μmi n
diameter and 60 to 140μm in length,” giving length to
diameter ratio of about 5 to 1. Recent studies, relying
on enzymatic isolation of myocytes into suspension from
surgical specimens [5–14], commonly model myocytes as
ellipticcylindersofvariableeccentricitiesandlengthtowidth
ratios under assorted conditions [5–7]. Variations between
these models, arising from disparate methodologies, call
for further inquiry to resolve their causes. Cross-sectional
proﬁles of myocytes, whether isolated or in sections, display
a daunting irregularity of outline, especially of major axis,
although less so of the minor axis. Measurements of minor
axis are therefore emphasized in this report of ﬁndings with
H&E-stainedparaﬃnsectionsofforensicautopsyspecimens.
Left ventricular mass increases in many hyperergopathic
states, often culminating in systolic dysfunction [15, 16].
Behavior by the full range of myocyte sizes, and not just
their average, merits attention. Several authors [7–10]h a v e
reported unimodal distribution curves of myocyte sizes,
consistently showing conspicuous upward skewness. These
authors did not report statistical curve ﬁtting; however,
graphic inspection raised the possibility of log normal ﬁts,
which could imply that the smallest and the largest myocytes
may all respond alike [7–9], a possibility seldom discussed.
Grant et al. [17] stated a rarely encountered suggestion that
“eccentric hypertrophy is analogous to normal growth, the
process which converts a neonatal left ventricle into an adult
chamber.” It is therefore easy to envision that the process
could become exaggerated by uncommon growth into the
tallest statures, which could be viewed as a form of eccentric
hypertrophy that is progressing toward pathological thresh-
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Myocyte breadth clearly increases in company with
concentric hypertrophy irrespective of etiology [1–9, 12, 13].
However, the behavior of myocyte breadth as the chamber
dilates is controversial [5, 6, 12, 13, 17]. Data in the present
report oﬀer some comment upon this question.
Assessment of myocyte volume is problematic at best
in the data reported here. However, some rough estimates
applicable to group averages can be explored. This is done
here for only one limited purpose, to relate myocyte sizes to
body weight.
This study in a series of 104 forensic autopsies included
all encountered instances of cardiomegaly (excluding coro-
nary heart disease), instances that were often later attributed
to hypertension, obesity, or idiopathic cardiomyopathy (46
cases), aortic stenosis (4), mitral deformity (1), or cor
pulmonale (2).Techniques for measuring myocyte sizes were
developed and applied to this series of specimens.
2.Methods
2.1. Subjects. Between November 2007 and May 2009, the
Orleans Parish Coroner’s Oﬃce supplied 104 specimens. All
cases with cardiomegaly (whole heart weight >399gm in
women and >449gm in men), other than coronary heart
disease, were included. Death was attributed to cardiovascu-
lar causes in 42 cases and to noncardiovascular causes in 62
cases(with46instancesofviolenceordrugs).Leftventricular
hypertrophy (LVH) occurred in 33 of the 42 cardiovascular
cases and 20 ofthe 62 noncardiovascular cases (many chosen
because of the presence of incidental LVH). Noncardiovas-
cular cases were chosen to have <12 hours postmortem
interval, no immediately preceding hospitalization, and
cause of death unrelated to cardiovascular disease. The
42 cases classed as cardiovascular deaths included chronic
renal failure (N = 1), cerebrovascular disorders (3), aortic
stenosis (4), mitral deformity (1), pulmonary conditions
(8, cor pulmonale, pulmonary embolus, arrhythmogenic
right ventricular dysplasia), dilated hypertrophy (23), and
LVH without dilatation (2). Hypertrophic cardiomyopathy,
as deﬁned by myocyte disarray [18], was not encountered.
Clinical information, most notably on hypertension, was not
available in these forensic cases, because review of clinical
records was omitted; therefore the IRB declared this autopsy
study exempt from their review. Body weight was unavailable
in the ﬁrst 34 cases.
2.2. Left Ventricular Weight (LVW), Hypertrophy (LVH),
Chamber Diameter (CD), and Wall Thickness (LVT). Ven-
tricles of the fresh heart were divided from the atria,
separated, and the epicardial fat dissected away. The method
of Bove et al. [19] was modiﬁed by using the fresh rather
than the formalin-ﬁxed heart and by placing the trabeculae
carneae and papillary muscles from the right side of the
interventricular septum with the right ventricle. Data of
Deveraux et al. [20] were used to calculate 219grams in
men and 199grams in women as cutoﬀ points for LVH.
Chamber diameter (CD) was measured with a ruler on the
high chordal plane (touching the edges of the opened mitral
leaﬂets) through the left ventricle. Thickness of lateral and
posterior walls was measured with a ruler and averaged to
ﬁnd LVT; these excludetrabeculae carneae and epicardial fat.
2.3. Preparations for Histology. A slice of myocardium pre-
senting the high chordal plane was formalin ﬁxed for 1–
6 days. Samples were excised from lateral, posterior, and
septal walls of the LV for sectioning both parallel and
perpendicularto the plane in theﬁrst 34 cases, and thereafter
only in the perpendicular plane. Paraﬃn-embedded samples
were sectioned at 6μm and stained with H&E. A subset
of specimens measured before and after processing into
slides showed mean shrinkage of 17.2% (SEM = 0.96%),
agreeing with published values [21, 22]. Adjustment by
1.21 = 1/0.828 was done upon subsequent histological
measurements, although this is not needed for the relative
comparisons of myocyte breadths in specimens reported
here.
2.4. Myocyte Proﬁles. Myocyte proﬁles in cross-section
(Figure 1(a)) were evaluated by imposing an ellipse upon
each proﬁle and measuring the minor axis of the idealized
outline. In longitudinal planes of cut, diameters were mea-
sured at positions exposing substantial lengths of uniform
width (Figure 1(b)). These measurements were made upon
black-and-white photographic prints using a digital caliper
accurate to 0.01mm. The ﬁrst 34 cases were used to explore
various sampling schemes. Thereafter, measurements were
taken in 60 anucleate cross-sectioned proﬁles from each of
4 sites in the LV free wall.
2.5. Sampling Variations. Myocyte proﬁles with nucleus
present were compared to proﬁles without visible nuclei as
a ratio, and the mean ratio departed substantially from 1.0
(mean = 1.195, SEM = 0.012, N = 34). In all following
analyses, therefore, nucleated proﬁles were omitted from
the samples for simplicity and consistently. The calibers
measured in longitudinal proﬁles held a ratio to those in
cross-sections of mean = 1.048 (SEM = 0 .012); since this
is signiﬁcantly diﬀerent from 1.0, longitudinal proﬁles were
omitted from all but one of the following analyses. The two
samples of LV free wall, posterior and lateral, yielded caliber
ratios to each other of mean = 1.021 (SEM = 0.014), which
does not diﬀer signiﬁcantly from 1.0 (P = .15), but the ratio
of caliber in the interventricular septum to that in the mean
free wall did diﬀer from 1.0 (mean = 0.944, SEM = 0.012,
P<. 001); hence the following analyses omit septal samples.
Between subendocardial and subepicardial sites the caliber
ratio had mean = 1.002 (SEM = 0.009, P = .84), hence
further analyses include sites at arbitrary depths into the
ventricular wall.
2.6. Myocyte Volume (MV) and Breadth (MB). In the
idealized model of a myocyte as an elliptic cylinder, its
dimensions are major axis, A, minor axis, B, and length L,
so that the volume is MV = πABL/4 = πr2L. The name
“width” is often given to the quantity 2r in the imaginary
circle of radius = r.H o w e v e r ,t h en a m e“ w i d t h ”i sa l s oCardiology Research and Practice 3
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Figure 1: Cross-sectional (a) and longitudinal (b) planes of cut as assessed in the ﬁrst 34 cases. H&E, bars = 30μm.
often used for the major axis or for the minor axis, making
the name “width” ambiguous. To avoid this ambiguity, the
name “breadth”, MB = myocyte breadth, is assigned to the
quantity2r calculatedfromtheminoraxis,asexplainednext.
2.7. Elliptic Eccentricity. Measurements in cross-sectioned
myocytes estimate the quantity B, minor axis. Measurements
on longitudinal planes of cut represent random diameters in
all directions across the elliptic myocyte, and their average
is a composite of these varying lengths. In the 34 specimens
measured in both ways, the means of the two methods
averaged a ratio of 1.048 (SEM = 0.012). By a method of
iteration it can be found that A/B = 11/10 yields a close
approximation to the observed ratio of longitudinal/cross
calibers = 1.048 given above. Knowing that AB/4 = r2 and
that A = 11B/10, the area becomes (πB2 × 11/10)/4 = πr2
and 2

B2((11/10)/4) = 2r = MB = 1.048 × Bi st h e
mean value for myocyte breadth. This is the function for
determining MB from the measured minor axis, B, and
conversion to MB allows comparisons with published data.
2.8. Sarcomere Length. In a subset of 59 specimens, Z-
bandswere countedwithin 30μmlongsegmentsofmyocytes
(Figure 1(b)). Counts divided by 30 (times 1.21 to correct
for preparation shrinkage) yields the sarcomere length. This
value averaged 1.68μm( S E M = 0.044μm, N = 59).
In a study of 6 hearts from ordinary human autopsies,
Gerdes et al. [14] found a comparable average sarcomere
length of 1.68μm in isolated myocytes. Hearts acquired
for enzymatic isolation of myocytes typically undergo rapid
ﬁxation of fresh organs; sarcomere lengths in those organs
have generally ranged around 2.0μm[ 8, 11, 13, 14]. The
ratio 1.68/2.0 = 0.84 is needed later as an adjustment to
allow transference of published diastolic data into formulas
developed here for systolic data in this study. Sarcomere
lengths measured here did not correlate with LVW, renal
evidence of hypertension, age, body length, body weight, or
skewness of the log normal ﬁts (P = .15 to .98).
2.9. Myocyte Length (ML). This study gives only limited and
somewhat peripheral attention to myocyte volume (MV).
This quantity has three spacial dimensions and therefore
seems appropriate for comparison with body weight (a
three-dimensional variable and the only one here calling
for some passing attention). The necessary data require
only mean values for each specimen and have no need for
individual measurements. Fortunately, some data oﬀering
a way to estimate these means are available in prominent
publications, and this estimation is examined next: in a
study of maturing spontaneously hypertensive rats from
birth to 24 months, many with LVH, Tamura et al. [13]
found that “... cell length should be directly reﬂected by
proportional alterations in chamber circumference.” In the
rats, circumference of 20mm corresponded to L = 135μm,
indicating 148 myocytes in the circumference if they are
envisioned in an imaginary arrangement end to end. A
similar proportionality in the human can only be inferred
indirectly from available sources. Using the data of Gerdes et
al. [5], taking chamber circumference data from Teichholz et
al.[23],healthynonhypertrophied heartshadL : MB = 7:1 ,
L = 134μm, and CD = 52mm, hence a value of 1,313
can be estimated for the number of myocytes envisioned
as circumferentially tandem, about 8.9 times those in the
rat. For dilated ventricles, L:MB = 11:1, L = 203μm,
and CD = 82mm, yielding 1,269 as the estimate for
number of circumferentially tandem myocytes, 8.6 times
that in the rat. The ratio of CD to L is nearly identical in
the human ventricles of both size ranges, in keeping with
the result seen in rats of near proportionality of myocyte
length to chamber diameter. In the data of this study, the
hearts lacking hypertrophy with mean CD = 28.0mmhad
mean MB = 17.4μm. Hence a simple formula can yield
approximate estimates of L for any particular CD; L =
7 × 0.84 × 17.4 × CD/28.0 = 3.654CD × 10
−3μm, where
the correction factor 0.84 adjusts for the systolic condition
of the specimens examined here, and 17.4/28.0 is taken as
the reference standard. This formula will be reconsidered in
the later discussion. The values for MV determined using4 Cardiology Research and Practice
this estimate of length correlates with MB3 with r = 0.59
(P<. 001).
2.10. Myocyte Numbers (MN). Total number of myocytes
(MN) in a ventricle is of limited interest in this report.
For that restricted purpose it can simplistically be calculated
as MN = 0.75 × LVW/MV, ignoring the negligible eﬀect
of speciﬁc gravity. The term 0.75 is a commonly reported
estimate [11] of myocytes as a proportion of total LVW
(myocyte volume fraction). MN calculated this way fails to
remain constant across the range of ventricular weights in
this data set, and it is possible to correct this defect by
using an adjustment factor, j. Although Tamura et al. [13]
reporttheirﬁndingsasfavoringapproximateproportionality
of myocyte length to chamber circumference, the regression
equation that they report actually contains a signiﬁcant
intercept term, showing departure from proportionality.
With the help of that regression equation, (1)c a nb e
derived
j = 1.2 ×(CD − 28.0). (1)
The adjusted myocyte length is (3.654 ×CD − j) ×10
−3 μm.
Myocyte numbers, using MV calculated with this adjusted
length, yields an adjusted quantity that does not correlate
with LVW (r =− 0.11, P = .29) and is therefore constant
across the range of ventricular weights; it also does not
correlate with race (P = .98), sex (P = .97), height (P =
.35), or body weight (P = .60), demonstrating the expected
constancy of myocyte numbers between these groupings.
This formula will be reconsidered in the later discussion.
Between MV and its adjusted value, r = 0.99 is found,
so that either can substitute for the other in correlation
analyses.
2.11. Fat and Lean Body Mass Proxies. Body mass index,
BMI = weight/height2 (kg/m2), is often used as a proxy
for body fat mass in proportionate comparisons between
individuals. Indexed left ventricular mass, LVW/height2.7
(Gm/m2.7), is also often used in comparisons of individuals,
implying that height2.7 is a proxy for lean body mass. In
this data set, the 70 cases with complete data revealed a
multiple correlation of these two proxies with total body
weight of r = 0.997, indicating that they jointly capture all
of the variations between individuals in total body weight,
so that their use as proxies passes this test of validity. The
standardized regression equationis weight = 0.347∗height2.7
+ 0.816∗BMI, implying that variation of fat mass between
individuals is more than twice as important as variation of
lean mass for determining total body weight.
2.12. Mean Arterial Pressure (MAP). Intimal thickness of
interlobular arteries in the renal cortex was measured in 100
cases, and mean arterial pressure (MAP) calculated using
a previously derived regression equation [24, 25]( M A P=
(S+2D)/3).
2.13. Statistical Method. These are all commonly used
techniques available in the SAS programs (SAS Institute,
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Figure 2: Observed frequency distributions and their log normal
ﬁtted curves for a 6-week-old infant (W = 15) and two selected
pools of left ventricles.
Cary NC). Some of the linear regression equations yielded
insigniﬁcant intercept terms so that the appropriate equa-
tions are forced through the origin; the correlation coeﬃ-
cients reported with these equations are those retaining the
intercept terms. For computing odds ratios in the logistic
regressions, the variables were measured in units of standard
deviation. For consistency and economy in testing of log
normal ﬁts to distribution curves only the Shapiro-Wilk test
was applied.
3.Results
3.1. Tests of Log Normal Fits. Figure 2 plots log normal
d i s t r i b u t i o nc u r v e sf o rM Ba sm e a s u r e di nt h eL Vo fa6 -
week-old infant (LVW = 15Gm), a pool of 6 cases of
low ventricular weights, and a pool of 6 cases with high
ventricular weights (mean and SD were closely alike in these
cases chosen for pooling). The low weight group was chosen
toillustrate adistributionthatfailstorejectthelognormalﬁt
(P>. 05 by Shapiro-Wilk test), while the high weight group
exempliﬁes the kind of misﬁt that is typical of curves that
signiﬁcantly depart from the lognormal. The log normal was
rejected as misﬁt in 33 of the 104 cases at P<. 1a n d5 3
cases at P<. 2 (32% and 51% resp. in Table 1, rather than
the randomly expected 10% and 20%, resp.). The skewness
had a mean of −0.140 (P<. 001 for diﬀerence from zero,
SD = 0.211), and was below zero in 73 specimens (70%).
Of the 33 seriously misﬁt cases, 22 displayed skewness <
−0.140 (correlation of skewness with P-values for the misﬁt
was r = 0.38, P<. 001 in the 104 cases). The 56 cases
with skewness > −.139 had P-values for the log normal ﬁts
which appear acceptably random (.1 >P>. 2b yc h i - s q u a r e
test in Table 1). Correlation of skewness with LVW was not
signiﬁcant (P = .16). The coeﬃcient of variation (CV) of
these logarithmic distributions ranged from 9.2 to 14.0%
(mean = 11.8%, SD = 1.2%); the correlation of CV with the
mean was r =− 0.05 with P = .68.Cardiology Research and Practice 5
Table 1: Number of cases according to signiﬁcance test for ﬁt of
LV myocyte breadths to log normal distribution by skewness of the
logarithmically transformed breadths.
Coeﬃcient of skewness†
P-level∗ All > −0.141 < −0.140
>.8 8 8 0
.6–.79 11 10 1
.4–.59 16 8 8
.2–.39 16 11 5
.1–.19 20 8 12
0–.09 33 11 22
∗Probability that the observed distribution of myocytebreadths ﬁts the log
normal form.
†The mean coeﬃcient in these 104 cases is −0.140.
3.2. Heterogeneity of LV Sites. With mean MB measured at 4
LV sites, the means can be compared in 6 pairings, testing
the diﬀerences by the Tukey test. Of the 624 pairings in
the pool of 104 cases, 174 (28%) yielded P<. 05, showing
members of the pairs to diﬀer signiﬁcantly from each other
far more often than by chance (5% = 31 pairings). The
numbers of pairs that diﬀered signiﬁcantly (heterogeneity)
decreased with negative log normal skewness (r = 0.25 with
P = .011) indicating dissociation of signiﬁcantly excessive
heterogeneity from negative skewness. The P-value for ﬁts of
thelog normal didnotcorrelate with heterogeneity(r = 0.05
with P = .59). By components of variance analysis, the
percentage of variance attributed to between sites variation
averaged only 6.28% as much as error variance within sites
(SD = 1.00%, range = −1.6 to 32.6%) in the 104 cases.
Heterogeneity did not correlate with between-site variance
across cases (r =− 0.11, P = .27).
3.3. Height. In the total set of 104 subjects, MB (a one
dimensional quantity) was found to correlate with body
length(BL,i.e.,heightinmeters). InFigure 3,theentir ebod y
of data revealed a correlation coeﬃcient of 0.67. However
46 subjects entered the series because of deaths related to
violence ordrugs, and these are thoughtto oﬀera reasonable
look at the free-living population not entering the data
set because of the incidental disease that happens also to
be found. Therefore, the regression equation ﬁt only to
t h e s e4 6s u b j e c t si sp l o t t e di nFigure 3, r = 0.43, P<
.001. This equation rejects an intercept term so that the
appropriate equation is forced through the origin (sloping
line in Figure 3):
MB = 10.53 × BL. (2)
This equation rejects race (P = .21) and sex (P = .19) as
oﬀering no additionally signiﬁcant correlation.
3.4. Myocyte Hypertrophy. Ac u t o ﬀ point for MB to deﬁne
hypertrophy of myocytes was explored with logistic regres-
sion with LVH as response variable. The resulting equation
gives MB = 19.7μma st h ec u t o ﬀ point; above that value
the mean of myocytes for that specimen can be declared
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hypertrophied. Oddsratio instandard deviationunits is55.5
(10.3 to 299.3 as 95% CI).
3.5. Chamber Diameter (CD). CD (in mm) correlated with
MB (μm) (r = 0.63); the regression accepts the intercept
term as signiﬁcant, showing lack of proportionality (sloping
line in Figure 4):
MB = 0.229 × CD+12.0
(0.229 has SE = 0.025, 12.0h a sS E= 0.91).
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Table 2:Meanmyocyte breadth (μm) according to LV hypertrophy,
dilatation and wall thickening (numbers of cases in parentheses).∗
Thickened No hypertrophy Hypertrophy present
Not dilated Dilated Not dilated Dilated
No 17.4A 16.8 19.4A 22.2A
(38.) (8.) (5.) (28.)
Yes 18.3A — 21.9A 24.3B
(5.) (0.) (5.) (15.)
ANOVA F (p)
Hypertrophy 32.8 (<.001)
Dilatation 11.6 (.001)
Thickening 2.8 (.04)
∗Hypertrophy isLVweight>219gformenand>199gforwomen,dilatation
is LV chamber diameter >33.3mm, wall thickening is LV free wall thickness
>16.5mm; all measurements are taken in the systolic state. Means within
a column that fail to share a symbol A or B diﬀer signiﬁcantly by t-test
(P<. 05).
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Figure 5: The sloping line plots (5)( r = 0.86). Vertical dashed line
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The standardized version is MB = 0.751 × CD. By logistic
regression, LVH could be predicted from CD:
CD = 33.3. (4)
This equation is plotted in Figure 4 as a dashed vertical line
which optimally separates dots from circles; when CD >
33.3mm then LVH is judged to be present. In standard
deviation units OR = 25.4( C I= 7.6 to 85.1).
3.6. LVW and Wall Thickness. In the 53 hearts without
dilatation, a cutoﬀ point for recognizing wall thickening was
explored with logistic regression, where myocyte hypertro-
phy (MB > 19.7μm) derived in Section 3.4 was predicted
using LV wall thickness, LVT. The resulting equation gives
LVT = 16.5μma st h ec u t o ﬀ point; above this value the left
ventricular free wall can be declared thickened. Odds ratio
in standard deviation units is 4.21 (1.56 to 11.33 CI). This
systolic value roughly corresponds to approximately 11.7μm
in diastole.
3.7. Concentric and Eccentric Hypertrophy. Using hypertro-
phy without dilatation to deﬁne concentric hypertrophy,
Table 2 shows this condition to display an appreciable
increase in myocyte breadth compared with normal hearts,
and this eﬀect is enhanced in the presence of wall thickening.
However, hypertrophied hearts with dilatation are far more
numerous than those without dilatation(43 versus10 cases),
and these also express a greater degree of MB thickening,
with the eﬀect exceptionally strong when the ventricular free
wall is thickened. The expected thinning of chamber wall
as hypertrophied hearts dilate is not manifest in the group
averages of Table 2 (derived from this forensic series of cases
with only 4 instances of aortic stenosis contributing to the
eccentric hypertrophy group).
3.8. Myocyte Volume (MV). LVW (gm, having three spacial
dimensions) has a linear relationship toMV (μm3) described
by (r = 0.86, sloping line in Figure 5)
LVW = 3.90 × MV + 72.0

R2 = .748, 3.90 has SE = 0.23, 72.0h a sS E= 11.2

.
(5)
The standardized equation is LVW = 0.86 MV. Logistic
regression relating LVH to MV yields
35,341 = MV. (6)
LVH is predicted to be present at values above the cutoﬀ,
and otherwise absent, hence that cutoﬀ deﬁnes myocyte
hypertrophy (OR = 931.0w i t hC I = 36.0t o>999.9 in
SD units). The cutoﬀ point for using MV to recognize
dilatation is found by logistic regression (vertical dashed line
in Figure 5):
37,927 = MV. (7)
When MV > 37,927μm3 the chamber is predicted to be
dilated (OR = 40.8, CI = 8.8 to 187.5 SD units).
3.9. Weight. In the 70 cases with data on body weight (BW
in kg, a quantity with 3 spatial dimensions) MB = 0.573 ×
BW + 14.3( r = 0.551). The retention of an intercept
term in this regression equation is inconvenient and results
from comparing a three-dimensional quantity, body weight,
to a one-dimensional quantity, MB. The three-dimensional
quantity,MV,althoughlimitedbyuncertaintiesinitsindirect
determination, correlates with BW (r = 0.50), and the
regression equation rejects entry of an intercept term so that
the appropriate equation is forced through the origin:
MV = 435 × BW (8)
This equation rejects entry of height (P = .92), body mass
index (P = .21),sex (P = .61),and race (P = .43).By logistic
regression, the optimal classiﬁcation of cases with myocyte
hypertrophy from those without is 104.1 = BW (OR = 3.33,
CI = 1.72 to 6.45 in SD units).Cardiology Research and Practice 7
3.10. Fat and Lean Body Mass. Proxies for these quantities
are introduced in methods. MV relates to these proxies
with multiple correlation of r = 0.50, thereby reproducing
the value of r = 0.50 just found for total body weight
(8), as expected for the joint action of the two proxies
together. The standardized regression equation for this
multiple relationship is
MV = 0.272 ×height
2.7 +0.223 × BMI (9)
which implies that lean and fat mass proxies are of equal
importance to the correlation with myocyte volume.
3.11. Mean Arterial Pressure (MAP). MAP, derived from
histological renal features in 100 of the cases, was found to
correlate with the measure of myocyte volume, MV (r =
0.21, P = .04). The intercept term is rejected so that the
appropriate regression equation is forced through the origin:
MV = 408 × MAP. (10)
By logistic regression the cutoﬀ value for myocyte hyper-
trophy is MAP = 106.5mmHg; above this level myocyte
hypertrophy becomes likely (OR = 1.68, range 1.10 to
2.58), and this cutoﬀ point seems reasonable for diagnosing
hypertension.
3.12. Myocyte Numbers (MN). MN, total myocytes in the
left ventricle, is calculated in this paragraph using formulas
explained with (1), et seq. These numbers do not vary
across groupings by LVW, race, sex, height, or body weight.
Ventricles with myocyte hypertrophy (MV > 35,341μm3)
revealed a small deﬁcit in cell numbers compared with
normal ventricles (mean MN = 5.90 versus 6.69 × 109 cells,
resp., SEM = 0.19 for both means, P<. 001). Similarly,
dilatedventricles(CD > 33.3mm)alsoshowedasmalldeﬁcit
compared to normal (mean = 5.90 versus 6.89 × 109 cells
resp., SEM = 0.20 for both means, P<. 001).
4.Discussion
Frequency distribution curves of MB in the present data
set, in agreement with numerous published graphs [7–
10], showed unimodal curves with conspicuous upward
skewness. Fitting the log normal form in these data was
seldom rejected by Shapiro-Wilk signiﬁcance tests (32% of
cases rejected at P<. 1), and the rejections appeared trivial
to graphic inspection (Figure 2,r i g h tf r a m e ) .T h em e a n so f
thelog normal curveswere uncorrelated with the coeﬃcients
of variation across the range of ventricular sizes. This is
the pattern expected if myocyte hypertrophy follows an
allometric growth model [26], which would indicate that
the enlargement of each myocyte remains proportional to
that of all others (in the absence of focal injury), a ﬁnding
consistent with previous reports [7–9]. This inference might
oﬀer insights into the depressed contractility that aﬀects
myocytes as they elongate and approach failure in the dilated
ventricle [15, 16]. Houser and Margulies [15], for instance,
implythatthedepressed contractilityinsystolic heart failure,
in the absence of coronary heart disease, is population wide
over all myocytes, a suggestion consistent with Figure 2.
Another proposal, as reviewed by Anversa et al. [27], for
instance, is that tissue oxygenation is faulty and increases
the vulnerability of the hypertrophied myocardium. This
mechanism would presumably act selectively upon the most
hypertrophied myocytes while sparing the smallest ones, a
mechanism hardtoreconcilewiththebehavioroflognormal
curves during hypertrophy.
The log normal distributions also seem inconsistent with
the proposals of longitudinal splitting in the myocytes that
are enlarged beyond the “limit of hypertrophy” [2], and
of substantial cell loss to apoptosis or necrosis [16]. Those
two eﬀects might be expected to act selectively upon the
most hypertrophied myocytes thereby truncating the upper
range of the log normal distributions to generate a negative
skewness coeﬃcient. In the present data set, an infrequent
andweaknegativeskewnesshappenedasofteninthesmallest
as in the largest ventricles thus showing no association with
hypertrophy.
The lengths of minor axes in cross-sectioned myocytes,
as reﬂected in their proxy, MB, are not exactly random in
theirdistributionamongleftventricularsamples. Onaverage
the variance between sites exhibits an excess of 6.28% above
the expected value of0% of the within-site random variance.
These departures haveonly few and inconsistent associations
with anatomic location throughout the left ventricular
free wall, a ﬁnding in agreement with some authors, for
example, Campbell et al. [9]“ ... there is no consistent
pattern of regional myocyte size diﬀerences in normal
mammalian hearts.” These relativelysmall departuresalso do
not contribute measurably to misﬁts of the widely ranging
myocyte sizes to the log normal distributions or to their
negative skewness. These departures may be of importance
to cardiac function, but their signiﬁcance seems negligible in
the present analysis.
Zak [3] summarizes a widely held viewpoint that “...
more than 90% of human postnatal growth of the heart
can be accounted for by hypertrophy of the ﬁbers present
at birth.” It appears that this process may continue with
growth into the upper ranges of stature (Figure 3), and
that the larger hearts in taller people are not manifesting
physiological growth but instead are undergoing hypertro-
phy toward pathological boundaries. As stated by Grossman
et al. [28] “in our concept, the eccentric hypertrophy by
which a child’s heart becomes that of an adult represents
a physiologic “volume overload,” and may very well uti-
lize the same mechanisms as seen with the pathologic
volume overload of valvular insuﬃciency.” Equation (2)
shows average myocyte breadth to increase in direct pro-
portion to height, a result expected if tall persons did
not receive any supplementary endowment of myocytes in
infancy. These ﬁndings generate the conclusion that, in
some special situations, it may be unwise to index left
ventricular mass to height [26], a procedure that would
artifactually discard a signiﬁcant component of meaningful
hypertrophy.
As the left ventricular chamber diameter (CD) is found
to be increasingly dilated from one specimen to another, the8 Cardiology Research and Practice
way that myocyte breadth (MB) follows or fails to follow
thischangeiscontroversial.Gerdes[12] summarizes anoften
encountered suggestion that, “volume overloading leads to
proportionate growth in chamber diameter and wall thick-
ness, which are reﬂected at the cellularlevelby proportionate
growth of myocyte L (length) and CSA (cross-sectional
area).” However, Gerdes in the same article later appears
to conﬁne the prior statement to compensated dilatation,
because “... myocyte L/W (length/width) increased dra-
matically in humans with congestive heart failure due to
ischemic and dilated cardiomyopathy.” In fact, some data
fromGerdesetal.[6]oﬀertabulationsfornormalanddilated
failing hearts which indicate virtually no increase of myocyte
breadth with dilated hypertrophy. The data in Figure 3 are
generally intermediate between these extremes. Compared
with the normal at MB/CD = 16/20 = 0.8( Figure 4),
only one of the hypertrophied hearts fails to fall short of
this value, so that a consistent proportionality of chamber
diameter to myocyte breadth is unambiguously rejected in
these data. The mean MB in ventricles without hypertrophy
is 17.4μm, and all of the hypertrophied ventricles exceed
this value, so that a consistent lack of increase in MB
with dilatation is ﬁrmly rejected. The cube of myocyte
breadth, MB3, has a disappointing correlation with MV,
r = 0.59, so that this cubic term can substitute for MV
only crudely for use, perhaps, in some exploratory settings
[12].
The Methods section (Elliptic eccentricity) gives a value
of 1.048 for the ratio of major/minor axis in this data
set. This outcome seems consistent with prior studies of
autopsy materials, but is inconsistent with ﬁndings from
enzymatically isolated myocytes wherein eccentricities are
typically reported in the range of 2.0. There appears to be an
unexplained consistent discrepancy between autopsy studies
of tissue sections as compared with myocytes enzymatically
isolated from surgical specimens. Although not widely
entertained, one possibility is [7], “... some investigators
have suggested that cardiac myocytes may assume a more
ﬂattened shape after dissociation compared with their shape
in intact tissue specimens.” This proposal may have some
support from measurements of isolated myocyte thicknesses
by confocal microscopy [14]. This uncertainty bears upon
the next topic to be considered.
An adjusted value of myocyte volume used here for
some limited exploratory purposes adopts the axiom that,
on average, myocyte numbers are alike across the range of
ventricular sizes, which allows empirical construction of (1),
introducing an adjustment factor j. The origin of factor j
began from the data of Tamura et al. [13]i nw h i c ht h e
myocytelengthdoesnotquitekeepupasthe chamberdilates
with growth and hypertrophy. This outcome implies that the
laggard myocyte length must be compensated by increased
myocytenumbers, byadegreeof“slippage”betweenadjacent
parallel myocytes [2, 12, 13], or by some other means. Per-
haps increased width of a few cross-wise myocytes could ﬁll
the gap. The matter remains to be clariﬁed. The conclusions
based here on estimates of MV should therefore be treated as
provisional.
5.Conclusions
Equation (8) reports the ﬁnding that average myocyte
volume can be described as proportional to total body
weight. This equation rejects entry of height, as expected
if lean and fat body mass contribute equally. Equation
(9) tentatively supports this same conclusion. Total body
weight also suﬃces to statistically explain the sex diﬀerence
in myocyte size, the cutoﬀ point for myocyte hypertrophy
found here to be 104.1kg irrespective of sex, race, height, or
fatness (BMI). This surprising result derives from the little
used methods of measuring myocytes as a way to diagnose
hypertrophy. The conclusionis oﬀeredhere asa ﬁrst result of
its kind and only to serve as hypothesis in need of testing.
Conﬂictof Interests
The authors declare that there is no conﬂict of interests to
report.
Acknowledgment
The skilled technical input of Nicole Jackson was indispens-
able to this project.
References
[1] L. M. Ashley, “A determination of the diameters of ventricular
myocardial ﬁbers in man and other mammals,” American
Journal of Anatomy, vol. 77, no. 11, pp. 325–359, 1945.
[2] A. J. Linzbach, “Heart failure from the point of view of
quantitative anatomy,” The American Journal of Cardiology,
vol. 5, no. 3, pp. 370–382, 1960.
[3] R. Zak, “Development and proliferative capacity of cardiac
muscle cells,” Circulation Research, vol. 35, supplement 2, pp.
17–26, 1974.
[4] L. H. Opi, “Mechanisms of cardiac contraction and relax-
ation,” in Heart Disease: A Textbook of Cardiovascular
Medicine,E .B r a u n w a l d ,D .P .Z i p e s ,a n dP .L i b b y ,E d s . ,v o l .
1, p. 443, W. B. Saunders, Philadelphia, Pa, USA, 2001.
[5] A. M. Gerdes, J. M. Capasso, J. Schaper et al., “Structural
remodeling and mechanical dysfunction of cardiac myocytes
in heart failure,” Journal of Molecular and Cellular Cardiology,
vol. 27, no. 3, pp. 849–865, 1995.
[ 6 ] A .M .G e r d e s ,S .E .K e l l e r m a n ,K .B .M a l e c ,a n dD .
D. Schocken, “Transverse shape characteristics of cardiac
myocytes from rats and humans,” Cardioscience,v o l .5 ,n o .1 ,
pp. 31–36, 1994.
[7] A. Zafeiridis, V. Jeevanandam, S. R. Houser, and K. B.
Margulies, “Regression of cellular hypertrophy after left
ventricular assist device support,” Circulation, vol. 98, no. 7,
pp. 656–662, 1998.
[8] B. Korecky and K. Rakusan, “Normal and hypertrophic
growth of the rat heart: changes in cell dimensions and
number,” The American journal of physiology, vol. 234, no. 2,
pp. H123–128, 1978.
[9] S. E. Campbell, B. Korecky, and K. Rakusan, “Remodeling of
myocyte dimensions in hypertrophic and atrophic rat hearts,”
Circulation Research, vol. 68, no. 4, pp. 984–996, 1991.
[10] S. Said, T. Tamura, and A. Martin Gerdes, “Measurement of
isolated myocyte volume using the Coulter models Z2 andCardiology Research and Practice 9
ZM/C256: a comparison of instrument function,” BioTech-
niques, vol. 25, no. 3, pp. 522–525, 1998.
[11] A. M. Gerdes, J. A. Moore, and J. M. Hines, “Regional
diﬀerences in myocyte size in normal rat heart,” Anatomical
Record, vol. 215, no. 4, pp. 420–426, 1986.
[12] A. M. Gerdes, “Cardiac myocyte remodeling in hypertrophy
and progression to failure,” Journal of Cardiac Failure,v o l .8 ,
no. 6, pp. S264–S268, 2002.
[ 1 3 ]T .T a m u r a ,T .O n o d e r a ,S .S a i d ,a n dA .M .G e r d e s ,“ C o r -
relation of myocyte lengthening to chamber dilation in the
spontaneously hypertensive heart failure (SHHF) rat,” Journal
of Molecular and Cellular Cardiology, vol.30, no.11, pp. 2175–
2181, 1998.
[ 1 4 ]A .M .G e r d e s ,T .O n o d e r a ,T .T a m u r ae ta l . ,“ N e wm e t h o dt o
evaluate myocyte remodeling from formalin-ﬁxed biopsy and
autopsy material,” Journal of Cardiac Failure,v o l .4 ,n o .4 ,p p .
343–348, 1998.
[15] S. R. Houser and K. B. Margulies, “Is depressed myocyte
contractility centrally involved in heart failure?” Circulation
Research, vol. 92, no. 4, pp. 350–358, 2003.
[16] A. M. Katz, “Cardiomyopathy of overload: a major deter-
minant of prognosis in congestive heart failure,” The New
England Journal ofMedicine,vol.322,no.2,pp.100–110,1990.
[17] C. Grant, D. G. Greene, and I. L. Bunnell, “Left ventricular
enlargement and hypertrophy. A clinical and angiocardio-
graphic study,” The American Journal of Medicine, vol. 39, no.
6, pp. 895–904, 1965.
[18] B. J. Maron and W. C. Roberts, “Quantitative analysis of
cardiac muscle cell disorganization in the ventricular septum
of patients with hypertrophic cardiomyopathy,” Circulation,
vol. 59, no. 4, pp. 689–706, 1979.
[ 1 9 ]K .E .B o v e ,D .T .R o w l a n d s ,a n dR .C .S c o t t ,“ O b s e r v a t i o n s
on the assessment of cardiac hypertrophy utilizing a chamber
partition technique,” Circulation, vol. 33, no. 4, pp. 558–568,
1966.
[20] R. B. Devereux, K. Wachtell, E. Gerdts et al., “Prognostic
signiﬁcance of left ventricular mass change during treatment
of hypertension,” Journal of the American Medical Association,
vol. 292, no. 19, pp. 2350–2356, 2004.
[21] G. F. Bahr, G. Bloom, and U. Friberg, “Volume changes
of tissues in physiological ﬂuids during ﬁxation in osmium
tetroxide or formaldehyde and during subsequent treatment,”
Experimental Cell Research, vol. 12, no. 2, pp. 342–355, 1957.
[ 2 2 ]R .J .S i e g e l ,K .S w a n ,G .E d w a l d s ,a n dM .C .F i s h b e i n ,
“Limitations of postmortem assessment of human coronary
artery size and luminal narrowing: diﬀerential eﬀects of tissue
ﬁxation and processing on vessels with diﬀerent degrees of
atherosclerosis,” Journal of the American College of Cardiology,
vol. 5, no. 2 I, pp. 342–346, 1985.
[23] L. E. Teichholz, T. Kreulen, M. V. Herman, and R. Gorlin,
“Problems in echocardiographic volume determinations: ech-
ocardiographic-angiographic correlations in the presence or
absence of asynergy,” The American Journal of Cardiology,v o l .
37, no. 1, pp. 7–11, 1976.
[24] R.E. Tracy, D. N.Lanjewar,K.G. Ghorpade,A.G. Valand,and
S.R.Raghuwanshi,“Renovasculopathies in elderly normoten-
sives of Bombay, India,” Geriatric nephrology and urology,v o l .
7, no. 2, pp. 101–109, 1997.
[25] R. E. Tracy, “The heterogeneity of vascular ﬁndings in
the kidneys of patients with benign essential hypertension,”
Nephrology Dialysis Transplantation, vol. 14, no. 7, pp. 1634–
1639, 1999.
[ 2 6 ]G .D eS i m o n e ,S .R .D a n i e l s ,R .B .D e v e r e u xe ta l . ,“ L e f t
ventricular mass and body size in normotensive children
and adults: assessment of allometric relations and impact of
overweight,” Journal of the American College of Cardiology,v o l .
20, no. 5, pp. 1251–1260, 1992.
[27] P. Anversa, R. Ricci, and G. Olivetti, “Guantitative structural
analysis of the myocardium duringphysiological growth and
induced cardiac hypertrophy: a review,” Journal of the Ameri-
can College of Cardiology, vol. 7, no. 5, pp. 1140–1149, 1986.
[28] W. Grossman, D. Jones, and L. P. McLaurin, “Wall stress and
patterns of hypertrophy in the human left ventricle,” Journal
of Clinical Investigation, vol. 56, no. 1, pp. 56–64, 1975.